U.S. Markets close in 2 hrs 38 mins
  • S&P 500

    4,121.08
    -18.98 (-0.46%)
     
  • Dow 30

    32,813.95
    -18.59 (-0.06%)
     
  • Nasdaq

    12,462.53
    -181.93 (-1.44%)
     
  • Russell 2000

    1,908.85
    -32.36 (-1.67%)
     
  • Crude Oil

    90.14
    -0.62 (-0.68%)
     
  • Gold

    1,812.80
    +7.60 (+0.42%)
     
  • Silver

    20.50
    -0.11 (-0.53%)
     
  • EUR/USD

    1.0223
    +0.0028 (+0.28%)
     
  • 10-Yr Bond

    2.7860
    +0.0210 (+0.76%)
     
  • GBP/USD

    1.2079
    -0.0003 (-0.02%)
     
  • USD/JPY

    135.0600
    +0.0870 (+0.06%)
     
  • BTC-USD

    23,113.56
    -868.81 (-3.62%)
     
  • CMC Crypto 200

    536.86
    -20.49 (-3.68%)
     
  • FTSE 100

    7,488.15
    +5.78 (+0.08%)
     
  • Nikkei 225

    27,999.96
    -249.28 (-0.88%)
     

Alimera Sciences to Present at the LD Micro Invitational XII Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Alimera Sciences, Inc.
Alimera Sciences, Inc.

ATLANTA, June 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the LD Micro Invitational XII Conference. The conference is being held on June 7 – 9, 2022 at the Four Seasons in Westlake Village, CA.

Presentation Date:

 

June 7, 2022

Time:

 

9:30am (PDT)

Webcast Link:

 

LDinv12.mysequire.com

Mr. Eiswirth will be available for one-on-one meetings with registered attendees of the conference.

About Alimera
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:
Cindy Rizzo
for Alimera
ir@alimerasciences.com

For investor inquiries:
Scott Gordon
for Alimera               
scottg@coreir.com